Sign in

CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811567056
Phone
206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-08-01 Emergent BioSolutions Inc. 10% owner Other disposition −20,230,074 0
2016-07-29 Emergent BioSolutions Inc. 10% owner Other acquisition +20,228,849 20,229,849
2016-07-29 Emergent BioSolutions Inc. 10% owner Other acquisition +20,229,074 20,230,074

Page 27 of 27 · 523 trades